enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
11.96
+0.50 (4.32%)
At close: Mar 9, 2026, 4:00 PM EDT
11.83
-0.13 (-1.06%)
After-hours: Mar 9, 2026, 4:00 PM EDT
enVVeno Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
7.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lifeward | 24.50M |
| Allurion Technologies | 17.21M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Biomerica | 4.46M |
| Intelligent Bio Solutions | 3.58M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
NVNO News
- 6 days ago - NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - GlobeNewsWire
- 4 weeks ago - enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Accesswire
- 7 weeks ago - enVVeno Medical Announces Reverse Stock Split - Accesswire
- 3 months ago - enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - Accesswire
- 4 months ago - enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Accesswire
- 4 months ago - enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 5 months ago - enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment - Accesswire
- 6 months ago - enVVeno Medical Updates Regulatory Status of VenoValve(R) - Accesswire